Gempharmatech Co. Ltd. A (688046) — Cash Flow Reinvestment Rate
Gempharmatech Co. Ltd. A (688046) has a Cash Flow Reinvestment Rate of 1.36x as of December 2024, reinvesting CN¥123.04 Million (capex CN¥113.68 Million plus investments CN¥9.36 Million) from operating cash flow of CN¥90.31 Million. Check Gempharmatech Co. Ltd. A cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Gempharmatech Co. Ltd. A Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Gempharmatech Co. Ltd. A across 6 annual periods. Explore 688046 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Gempharmatech Co. Ltd. A (2019–2024)
Year-by-year capital reinvestment analysis for Gempharmatech Co. Ltd. A. For live market cap and broader valuation context, see 688046 company net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.36x | CN¥123.04 Million | CN¥90.31 Million | CN¥113.68 Million | ▼ -29.3% |
| 2023 | 1.93x | CN¥224.51 Million | CN¥116.57 Million | CN¥205.90 Million | ▼ -82.8% |
| 2022 | 11.18x | CN¥1.18 Billion | CN¥105.98 Million | CN¥190.31 Million | ▲ +186.1% |
| 2021 | 3.91x | CN¥442.81 Million | CN¥113.31 Million | CN¥89.07 Million | ▲ +69.0% |
| 2020 | 2.31x | CN¥300.17 Million | CN¥129.79 Million | CN¥167.07 Million | ▲ +75.3% |
| 2019 | 1.32x | CN¥85.93 Million | CN¥65.12 Million | CN¥45.66 Million | — |